Titlebook: Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics; Jianguo Tao,Eduardo Sotomayor Book 2012 Springer Science+Busine

membrane

Chronic Myeloproliferative Disorders:From Molecular Pathogenesis to Targeted Therapy,f safe and effective therapies will soon follow. This principle has previously been demonstrated in malignant hematology by the effectiveness of . kinase inhibitors in chronic myelogenous leukemia (CML). A new opportunity to deliver on this premise is underway in the closely related non-CML myeloproliferative neoplasms (MPNs).